2-Morpholinonicotinic Acid,
423768-54-1,
2-(morpholin-4-yl)pyridine-3-carboxylic acid,
2-(4-Morpholino)nicotinic acid,
2-morpholin-4-ylpyridine-3-carboxylic acid,
PubChem19585,
BAS 04892295,
2-MorpholinonicotinicAcid,
AC1MCR2E,
AC1Q72DH,
SCHEMBL353809,
CTK1D5461,
2-Morpholin-4-yl-nicotinic acid,
DTXSID40380191,
HMS1678H11,
ZINC159012,
KS-00000CD0,
ANW-55031,
MFCD03086193,
SBB094031,
2-morpholinopyridine-3-carboxylic acid,
AKOS000213416,
AC-2875,
MCULE-2824187286,
RP04676,
RTR-016608,
SDCCGMLS-0066054.P001,
TRA0040619,
AK-77602,
AN-13541,
SC-21876,
SY003211,
AB0041343,
AB1001550,
TR-016608,
3-Pyridinecarboxylicacid,2-(4-morpholinyl)-,
FT-0613111,
Y9080,
2-Morpholinopyridine-3-carboxylic acid, 97%,
3-Pyridinecarboxylicacid, 2-(4-morpholinyl)-,
EN300-57729,
Z-3348,
MFCD03086193 (97+%),
6Z-0242,
J-510133,
I14-17409,
F8889-0687,
null,
C10H12N2O3,
CID2776568,
2-chloro-N-[5-(morpholin-4-ylsulfonyl)-2-pyrrolidin-1-ylphenyl]acetamide hydrochloride,